Latest post

Indonesia’s Jan-Nov budget deficit at 1.81% of GDP

JAKARTA (Reuters) – Indonesia’s budget deficit for January to November was 401.8 trillion rupiah ($25.27 billion) or 1.81% of gross domestic product, its finance minister said on Wednesday. Total (EPA:TTEF) revenue for the January-November period rose 1.3% in annual terms…

Exclusive-Chinese authorities are considering a weaker yuan as Trump trade risks loom, sources say

(Reuters) – China’s top leaders and policymakers are considering allowing the yuan to weaken in 2025 as they brace for higher trade tariffs in a second Donald Trump presidency in the United States. The contemplated move reflects China’s recognition that…

Thai cabinet approves measures to ease household debt

BANGKOK (Reuters) – Thailand’s cabinet on Wednesday approved debt support measures, including interest suspensions and reduced principal payments, to help tackle household debt, Prime Minister Paetongtarn Shinawatra said. The measures will help retail borrowers and smaller businesses, she told a…

Romanian pro-European parties agree to quickly form broad coalition government

BUCHAREST (Reuters) – Romania’s pro-European parties reached a firm commitment late on Monday to form a governing majority that cordons off the hard right and potentially endorses a single candidate for a re-run of the country’s annulled presidential election. The…

Bank of England set to stay in central bank slow lane and keep rates on hold

By William Schomberg LONDON (Reuters) – The Bank of England looks set to keep interest rates on hold next week as it moves more slowly to cut borrowing costs than central banks in Europe and the United States. The BoE…

Q32 Bio: Oppenheimer slashes price targeton mixed trial results

Investing.com– Oppenheimer slashed its price target on Q32 Bio Inc (NASDAQ:QTTB) after the firm released mixed results from two ongoing phase 2 trials for its Bempikibart treatment. Oppenheimer slashed its price target on the stock to $20 from $80, but…